Insilico Medicine: An Extraordinary Journey

From its founding in 2014 at the Emerging Technology Centers on Johns Hopkins campus, to the launch of its target discovery and drug design platform, to its global expansion into a leading generative AI-driven biotech company advancing AI-designed drugs into human clinical trials, Insilico Medicine has had an extraordinary journey.
Anyone interested in being part of drug discovery history and telling Insilico Medicine's story should check out our documentary hackathon, Docuthon, happening now! insilico.com/docuthon